Status:
UNKNOWN
Sarcopenia Screening in Elderly Individuals
Lead Sponsor:
Kırıkkale University
Conditions:
Sarcopenia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease...
Detailed Description
Although aging occurs in all periods in the human body, physical, mental and physical aging becomes visible as you get older. This situation is caused by physiological aging, environmental factors, ex...
Eligibility Criteria
Inclusion
- Individuals aged 65 and over
- Their willingness to participate in the study
- A score of 24 or higher on the Mini Mental State Test (MMDT)
Exclusion
- Individuals under the age of 65
- Individuals who cannot communicate well
- Elderly individuals who cannot walk independently, have any orthopedic or neurological problems
- Individuals who do not want to participate in the study
- Individuals not eligible for bioimpedance analysis (pregnant individuals with pacemakers).
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
843 Patients enrolled
Trial Details
Trial ID
NCT06012422
Start Date
September 1 2023
End Date
January 1 2024
Last Update
August 25 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.